About: Therapeutic management of severe hypothermia with veno-arterial ECMO: where do we stand? Case report and review of the current literature

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Therapeutic management of severe hypothermia with veno-arterial ECMO: where do we stand? Case report and review of the current literature Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Therapeutic management of severe hypothermia with veno-arterial ECMO: where do we stand? Case report and review of the current literature
Creator	Ledoux, Aurélien Leger, Piehr
Source	PMC
abstract	BACKGROUND: Severe accidental hypothermia is associated with high morbidity and mortality. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides an efficient rewarming method with complete cardiopulmonary support. The use of VA-ECMO for this indication has greatly improved the vital and functional prognosis of patients. CASE PRESENTATION: We report a case of a 46-year-old patient who was treated for severe hypothermia with a temperature of 22.4 °C along with initial cardiac arrest, whose progression was favorable after the implementation of VA-ECMO support. Two months after initial cardiac arrest, the patient was reassessed and showed signs of complete recovery with regard to his mental and physical capacities. CONCLUSIONS: The recent international publications and groups of experts recommend the use of VA ECMO as the gold standard therapy to treat severe hypothermia. Therefore, it seems suitable to update the current knowledge on the topic by analysing the latest international publications. The performance of this technique calls into question ethical and economic factors. Two distinct medical teams tried to identify and regroup prognosis factors in predictive survival scores. They raise the question of the utility of these scores in clinical practice. Indeed, according to which survival rate should we proceed to prolonged resuscitation and implement VA-ECMO? Additional studies will be needed for external approval of these survival scores, and additional reflection by experts will be required.
has issue date	2020-04-21(xsd:dateTime)
bibo:doi	10.1186/s13049-020-00723-y
bibo:pmid	32316980
has license	cc-by
sha1sum (hex)	25c1785f7aa54f85cb2ae72df2981e81ffe6be3f
schema:url	https://doi.org/10.1186/s13049-020-00723-y
resource representing a document's title	Therapeutic management of severe hypothermia with veno-arterial ECMO: where do we stand? Case report and review of the current literature
has PubMed Central identifier	PMC7175497
has PubMed identifier	32316980
schema:publication	Scand J Trauma Resusc Emerg Med
resource representing a document's body	covid:25c1785f7aa54f85cb2ae72df2981e81ffe6be3f#body_text
is schema:about of	named entity 'The performance' named entity 'cardiac arrest' named entity 'Background' named entity 'hypothermia' named entity 'ECONOMIC FACTORS' named entity 'CURRENT' named entity 'REWARMING' named entity 'ACCORDING' named entity 'METHOD' named entity 'UPDATE' named entity 'OLD' named entity 'INITIAL' named entity 'PROVIDES' named entity 'TECHNIQUE' named entity 'NEEDED' named entity 'PERFORMANCE' covid:arg/25c1785f7aa54f85cb2ae72df2981e81ffe6be3f named entity 'therapy' named entity 'studies' named entity 'survival' named entity 'extracorporeal' named entity 'current' named entity 'Case' named entity 'factors' named entity 'prognosis' named entity 'analysing' named entity 'hypothermia' named entity 'ECMO' named entity 'ECMO' named entity 'clinical practice' named entity 'ECMO' named entity 'ECMO' named entity 'extracorporeal life support' named entity 'mortality rate' named entity 'Bradycardia' named entity 'ICU' named entity 'sequelae' named entity 'cardiac arrest' named entity 'CPR' named entity 'ECMO' named entity 'ECLS' named entity 'mmol/L' named entity 'Pseudomonas aeruginosa infection' named entity 'serum' named entity 'ECMO' named entity 'prognosis' named entity 'cardiopulmonary arrest' named entity 'mmol/L' named entity 'hypothermia' named entity 'coma' named entity 'Kidney function' named entity 'mortality rate' named entity 'metabolic' named entity 'intravascular' named entity 'ischemia' named entity 'cardio-pulmonary resuscitation' named entity 'post-hoc analysis' named entity 'core body temperature' named entity 'circulatory arrest' named entity 'LVEF' named entity 'ECLS' named entity 'anticoagulation' named entity 'ECLS' named entity 'mortality rate' named entity 'cardiac arrest' named entity 'lead to death' named entity 'beats per minute' named entity 'gold standard therapy' named entity 'hypothermia' named entity '1, 2' named entity 'Return of spontaneous circulation' named entity 'retrospective series' named entity 'serum' named entity 'hypothermia' named entity 'fibrin' named entity 'acidosis' named entity 'cardiovascular collapse' named entity 'odds ratio' named entity 'ECMO' named entity 'mydriasis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software